Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients
- PMID: 20872813
- DOI: 10.1002/jso.21725
Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients
Abstract
Background and objectives: Th2-dominant immunity and high neutrophil/lymphocyte ratios (NLRs) have been reported to reflect tumor progression, and so we examined whether the Th1/Th2 ratio and NLR can act as prognostic indicators or not.
Methods: Peripheral blood samples were taken within 1 week before and 14 postoperative days after curative gastrectomy using 157 gastric cancer cases for the measurement of both ratios. The proportions of Th1 cells (interferon γ-producing CD4 T cells), Th2 cells (interleukin-4-producing CD4 T cells) were counted by two-color flow cytometry analysis.
Results: There were significant differences in 5-year survival both between the high and low Th1/Th2 ratio groups, and between the high and low NLR groups. The pattern classifications before and after surgery in the Th1/Th2 ratio showed strongly significant differences in 5-year survival. NLR was especially influenced by tumor size, and there was a negative linear correlation between the two ratios before surgery.
Conclusions: The Th1/Th2 ratio may be a good prognostic indicator and may also be a promising marker for estimating the effectiveness of surgery. NLR may also be a good prognostic indicator and may be a valid marker of tumor recurrence, and it appeared that some interaction between lymphocytes and neutrophils had occurred.
2010 Wiley-Liss, Inc.
Similar articles
-
Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.Int J Clin Oncol. 2008 Dec;13(6):528-35. doi: 10.1007/s10147-008-0789-8. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093181
-
[Pre- and post-chemotherapy expressions of Th1 and Th2 type cytokines and their clinical significance in gastric cancer patients].Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):844-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173830 Chinese.
-
Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.Gastric Cancer. 2017 Mar;20(2):254-262. doi: 10.1007/s10120-016-0613-5. Epub 2016 May 5. Gastric Cancer. 2017. PMID: 27147244
-
Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.Anticancer Res. 2019 May;39(5):2583-2589. doi: 10.21873/anticanres.13381. Anticancer Res. 2019. PMID: 31092456
-
Prognostic Role of Neutrophil/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis.Clinics (Sao Paulo). 2018;73:e360. doi: 10.6061/clinics/2018/e360. Epub 2018 Jun 18. Clinics (Sao Paulo). 2018. PMID: 29924187 Free PMC article.
Cited by
-
Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer.Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E126-31. doi: 10.5489/cuaj.2523. Can Urol Assoc J. 2015. PMID: 25844098 Free PMC article.
-
Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer.World J Surg. 2011 Dec;35(12):2717-22. doi: 10.1007/s00268-011-1269-2. World J Surg. 2011. PMID: 21913135
-
Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.FEBS Open Bio. 2015 Aug 7;5:682-7. doi: 10.1016/j.fob.2015.08.002. eCollection 2015. FEBS Open Bio. 2015. PMID: 26380812 Free PMC article.
-
The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Sci Rep. 2017 Dec 1;7(1):16717. doi: 10.1038/s41598-017-16955-5. Sci Rep. 2017. PMID: 29196718 Free PMC article.
-
Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer.BMC Gastroenterol. 2022 Mar 16;22(1):122. doi: 10.1186/s12876-022-02205-0. BMC Gastroenterol. 2022. PMID: 35296257 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials